Anlotinib Not Yet Recruiting Phase 4 Trials for Locally Advanced Non-Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03743129Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer(ALTER-L029)